| Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale NCP Cross, HE White, T Ernst, L Welden, C Dietz, G Saglio, FX Mahon, ... Leukemia 30 (9), 1844-1852, 2016 | 58 | 2016 |
| Variant‐specific discrepancy when quantitating BCR‐ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay L Kjaer, V Skov, MT Andersen, A Aggerholm, P Clair, M Gniot, K Soeby, ... European Journal of Haematology 103 (1), 26-34, 2019 | 32 | 2019 |
| A multicenter prospective study on efficacy and safety of imatinib generics: a report from Polish Adult Leukemia Group imatinib generics registry T Sacha, J Góra-Tybor, M Szarejko, G Bober, O Grzybowska-Izydorczyk, ... American journal of hematology 92 (7), E125-E128, 2017 | 32 | 2017 |
| Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene M Barańska, K Lewandowski, M Gniot, M Iwoła, M Lewandowska, ... Journal of applied genetics 49, 201-203, 2008 | 32 | 2008 |
| Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation M Kaźmierczak, M Luczak, K Lewandowski, L Handschuh, A Czyż, ... Medical Oncology 30, 1-9, 2013 | 28 | 2013 |
| Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors K Lewandowski, M Gniot, M Wojtaszewska, Z Kanduła, R Becht, ... International journal of laboratory hematology 40 (3), 366-371, 2018 | 20 | 2018 |
| Frequency of BCR‑ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: a final report of the MAPTEST study K Lewandowski, K Warzocha, A Hellmann, A Skotnicki, W Prejzner, ... Polskie Archiwum Medycyny Wewnętrznej= Polish Archives of Internal Medicine …, 2009 | 19 | 2009 |
| Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome A Piekarska, L Gil, W Prejzner, P Wiśniewski, A Leszczyńska, M Gniot, ... Annals of Hematology 94, 1891-1897, 2015 | 17 | 2015 |
| Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study HE White, M Salmon, F Albano, CSA Andersen, S Balabanov, ... Leukemia 36 (7), 1834-1842, 2022 | 14 | 2022 |
| Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with … EM Wasilewska, B Panasiuk, M Gniot, A Sawicka, K Kozłowska, ... Cancer genetics 216, 1-9, 2017 | 9 | 2017 |
| Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm A Szczepaniak, M Machnicki, M Gniot, M Pępek, M Rydzanicz, R Płoski, ... International Journal of Hematology 110, 102-106, 2019 | 8 | 2019 |
| B-cell chronic lymphocytic leukemia with 11q22. 3 rearrangement in patient with chronic myeloid leukemia treated with imatinib K Lewandowski, M Gniot, M Lewandowska, A Wache, B Ratajczak, ... Case Reports in Medicine 2016, 2016 | 7 | 2016 |
| Imatinib generics in treatment of chronic myeloid leukemia; a prospective observation in large cohort of patients from polish (PALG) Imatinib Generics Registry T Sacha, J Gora-Tybor, M Szarejko, G Bober, O Grzybowska-Izydorczyk, ... Blood 128 (22), 629, 2016 | 5 | 2016 |
| Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t (9; 22; 22) and a constitutional translocation t (3; 7) M Jarmuż, R Kroll, A Przybyłowicz-Chalecka, B Ratajczak, M Gniot, ... Cancer Genetics and Cytogenetics 199 (1), 45-47, 2010 | 5 | 2010 |
| Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase … M Gniot, K Lewandowski, B Ratajczak, M Lewandowska, ... Cancer Genetics 207 (10-12), 503-510, 2014 | 4 | 2014 |
| Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net T Sacha, M Zawada, S Czekalska, I Florek, M Mueller, M Gniot, B Jaźwiec, ... Przeglad Lekarski 67 (7), 454-459, 2010 | 4 | 2010 |
| Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach M Wojtaszewska, R Stępień, A Woźna, M Piernik, P Sztromwasser, ... Molecular Diagnosis & Therapy, 1-12, 2022 | 2 | 2022 |
| High efficacy of dasatinib in maintenance therapy after allogeneic haematopoietic stem cell transplantation in patients with Philadelphia chromosome-positive acute … A Czyz, T Czerw, B Nasilowska-Adamska, J Dybko, D Kata, M Dutka, ... BONE MARROW TRANSPLANTATION 51, S270-S271, 2016 | 2 | 2016 |
| Całkowita remisja molekularna po podaniu nilotynibu u chorej na przewlekłą białaczkę szpikową w fazie przewlekłej z objawami nietolerancji imatynibu po zażyciu acetaminofenu M Lewandowska, M Gniot, K Lewandowski Hematologia 2 (B), 23-27, 2011 | 2 | 2011 |
| Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels K Lewandowski, Z Kanduła, M Gniot, E Paczkowska, PM Nawrocka, ... Annals of Hematology 101 (12), 2665-2677, 2022 | 1 | 2022 |
